NICE has rejected Johnson & Johnson’s oral prostate cancer drug Erleada (apalutamide) in patients with hormone-relapsed or hormone sensitive disease in first draft guidance. The cost-effectiveness ...

Find out why real estate is considered a good investment Barclay Palmer is a creative executive with 10+ years of creating or managing premium programming and brands/businesses across various ...

(Alliance News) - UK manufacturing showed further signs of stabilisation at the end of 2025, with output and new orders edging higher and the sector recording its strongest reading in more than a year ...